CDER Outlines CGMPs — and Exemptions — for Outsourcing Facilities

CDER spelled out current good manufacturing practices for drug compounders that register as outsourcers in a new draft guidance — and noted when the FDA does not intend to take regulatory action.
Source: Drug Industry Daily